UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (date of earliest event reported): February 29, 2016

                                 AMERICANN, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
------------------------          -----------------        -------------------
(State or other jurisdiction     (Commission File No.)       (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                   -----------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000


                          ----------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications  pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
    Exchange Act (17 CFR 240.13e-4(c))



<PAGE>


Item 1.01.  Entry Into a Material Definitive Agreement

     Previously  the Company  entered  into an agreement to purchase a 52.6 acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to December 29,  2015.  These  payments of $300,000  will be applied to the
purchase price.

     On December  22, 2015 the Company and the seller  amended the  agreement to
extend the closing date to February 29, 2016.

     As consideration  for the extension of the closing Date, the Company agreed
to increase  the  purchase  price for the  property to  $4,100,000  and paid the
seller  $100,000,  which will be applied to the  purchase  price if the  closing
occurs.

     On February  29, 2016 the Company and the seller  amended the  agreement to
extend  the  closing  date to the  earlier  of 5  business  days  following  the
Company's receipt of the DPH Approval (as defined below), or March 31, 2016.

     "DPH  Approval"  means the approvals by the Department of Public Health for
the  Commonwealth  of  Massachusetts  of  the  Company's  consulting  agreement,
development agreement and lease agreement relating to the MMCC.

     As consideration  for the extension of the closing Date, the Company agreed
to increase  the  purchase  price for the  property to  $4,150,000  and paid the
seller  $50,000,  which  will be applied to the  purchase  price if the  closing
occurs.

Item 9.01.  Financial Statements and Exhibits

Number      Description
------      ------------

 10.5       Seventh Amendment to Purchase and Sale Agreement






                                       2
<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: March 3, 2016                   AMERICANN, INC.


                                      By:  /s/ Benjamin J. Barton
                                           -------------------------------
                                          Benjamin J. Barton,
                                          Chief Financial Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101freetown3-16.txt", "description": "8-K RE FREETOWN AGREE", "secsgml_size_bytes": 5332}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "161481922"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (date of earliest event reported): February 29, 2016

                                 AMERICANN, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
------------------------          -----------------        -------------------
(State or other jurisdiction     (Commission File No.)       (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                   -----------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

                          ----------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications  pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
    Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

     Previously  the Company  entered  into an agreement to purchase a 52.6 acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to December 29,  2015.  These  payments of $300,000  will be applied to the
purchase price.

     On December  22, 2015 the Company and the seller  amended the  agreement to
extend the closing date to February 29, 2016.

     As consideration  for the extension of the closing Date, the Company agreed
to increase  the  purchase  price for the  property to  $4,100,000  and paid the
seller  $100,000,  which will be applied to the  purchase  price if the  closing
occurs.

     On February  29, 2016 the Company and the seller  amended the  agreement to
extend  the  closing  date to the  earlier  of 5  business  days  following  the
Company's receipt of the DPH Approval (as defined below), or March 31, 2016.

     "DPH  Approval"  means the approvals by the Department of Public Health for
the  Commonwealth  of  Massachusetts  of  the  Company's  consulting  agreement,
development agreement and lease agreement relating to the MMCC.

     As consideration  for the extension of the closing Date, the Company agreed
to increase  the  purchase  price for the  property to  $4,150,000  and paid the
seller  $50,000,  which  will be applied to the  purchase  price if the  closing
occurs.

Item 9.01.  Financial Statements and Exhibits

Number      Description
------      ------------

 10.5       Seventh Amendment to Purchase and Sale Agreement

                                       2
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: March 3, 2016                   AMERICANN, INC.

                                      By:  /s/ Benjamin J. Barton
                                           -------------------------------
                                          Benjamin J. Barton,
                                          Chief Financial Officer